Influenza Diagnostics Market
                     Influenza Diagnostics Market
Global Forecast to 2026
Influenza Diagnostics Market is 
expected to reach 
$ 1.1 Billion by 2026
Growing at a 
CAGR of  7.7% (2021 – 2026)
Influenza Diagnostics Market by Product (Test Kits, 
Instruments), Test Type (Traditional (RIDT, Viral Culture, 
Serological), Molecular (PCR, INAAT- NASBAT, TMABAS)), 
End User (Diagnostic Laboratories, Hospitals, Clinics), 
Region-Global Forecast to 2026
View detailed Table of Content here -
 https://www.marketsandmarkets.com/Market-Reports/influenza-dia
gnostic-market-222985562.html
Key Market Player
The major players in this market are Danaher Corporation (US), 
Siemens Healthineers (Germany), Thermo Fisher Scientific, Inc. 
(US), F. Hoffmann-LA Roche AG (Switzerland), Abbott 
Laboratories, Inc. (Us), Hologic, Inc. (US), bioMérieux SA 
(France), Quidel Corporation (US), Becton, Dickinson and 
Company (US), Meridian Bioscience (US), GenMark Diagnostics, 
Inc. (US), Luminex Corporation (US), Tecan Trading AG 
(Switzerland)
Thermo Fisher Scientific held the leading position in the influenza 
diagnostics market in 2020. The company maintains its leading 
position in this market through its strong global sales and 
distribution network. The company adopts organic growth and 
inorganic growth strategies to increase its dominance in this 
market. It also focuses on product approvals to complement its 
existing business segments.
In 2020, Becton, Dickinson and Company held the second position 
in the influenza diagnostics market. The company has maintained 
its leading position through its strong distribution networks across 
North America, Europe, and other developed countries. The 
company adopts organic growth strategies to increase its 
dominance in this market. It also focuses on product approvals to 
complement its existing business segments.